Insider Transactions in Q2 2021 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
2,003
-13.59%
|
$118,177
$59.85 P/Share
|
|
Jun 10
2021
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
5,689
-10.49%
|
$341,340
$60.0 P/Share
|
|
Jun 09
2021
|
Laura Brege Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+10.6%
|
-
|
|
Jun 09
2021
|
Christopher Christie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+31.43%
|
-
|
|
Jun 09
2021
|
Mark Froimson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+14.46%
|
-
|
|
Jun 09
2021
|
Yvonne Greenstreet Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+8.1%
|
-
|
|
Jun 09
2021
|
Paul J Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+13.99%
|
-
|
|
Jun 09
2021
|
Mark A. Kronenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+5.99%
|
-
|
|
Jun 09
2021
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+21.42%
|
-
|
|
Jun 09
2021
|
John P Phd Longenecker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+5.36%
|
-
|
|
Jun 09
2021
|
Donald C. Manning Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.89%
|
-
|
|
Jun 09
2021
|
Roy Winston Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+18.4%
|
-
|
|
Jun 09
2021
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+20.02%
|
-
|
|
Jun 09
2021
|
David M Stack CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+18.4%
|
-
|
|
Jun 09
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+15.0%
|
-
|
|
Jun 09
2021
|
Charles A. Reinhart Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+16.3%
|
-
|
|
Jun 09
2021
|
Max Reinhardt President, Rest of World |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+28.57%
|
-
|
|
Jun 09
2021
|
Dennis Mc Loughlin Chief Customer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+15.17%
|
-
|
|
Jun 09
2021
|
Gary W Pace Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,066
+0.82%
|
-
|
|
Jun 08
2021
|
Donald C. Manning Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,600
-9.95%
|
$158,600
$61.14 P/Share
|
|
Jun 07
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
2,278
-17.83%
|
$136,680
$60.5 P/Share
|
|
Jun 04
2021
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
630
-10.3%
|
$39,060
$62.19 P/Share
|
|
Jun 04
2021
|
Charles Anthony Laranjeira Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,117
-10.18%
|
$129,137
$61.04 P/Share
|
|
Jun 04
2021
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
1,895
-6.44%
|
$115,595
$61.04 P/Share
|
|
Jun 04
2021
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
1,222
-8.73%
|
$74,542
$61.04 P/Share
|
|
Jun 04
2021
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,648
-9.65%
|
$161,528
$61.04 P/Share
|
|
Jun 04
2021
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,047
-7.94%
|
$63,867
$61.04 P/Share
|
|
Jun 04
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
14,905
-19.6%
|
$909,205
$61.04 P/Share
|
|
Jun 04
2021
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3,930
-15.79%
|
$239,730
$61.04 P/Share
|
|
Jun 04
2021
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,276
-8.65%
|
$138,836
$61.04 P/Share
|
|
Jun 02
2021
|
Donald C. Manning Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,380
-8.35%
|
$147,560
$62.12 P/Share
|
|
May 13
2021
|
Gary W Pace Director |
SELL
Bona fide gift
|
Direct |
1,485
-1.14%
|
-
|
|
May 12
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
21,250
-7.71%
|
$1,296,250
$61.75 P/Share
|
|
May 12
2021
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+17.92%
|
$212,500
$10.81 P/Share
|
|
May 11
2021
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
21,250
-11.56%
|
$1,275,000
$60.98 P/Share
|
|
May 11
2021
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+17.92%
|
$212,500
$10.81 P/Share
|
|
Apr 13
2021
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
21,823
-26.85%
|
$1,462,141
$67.26 P/Share
|
|
Apr 13
2021
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,823
+12.47%
|
$851,097
$39.61 P/Share
|